Researchers visualize α-synuclein pathology in living patients with a neurodegenerative disorder
Beyond neurons: How cells called astrocytes contribute to brain disorders
30 August 2022Drugs effects of ketamine in mice can depend on the sex of the human experimenter
30 August 2022Researchers visualize α-synuclein pathology in living patients with a neurodegenerative disorder
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of α-synuclein in the brain. Now, scientists from Japan, in collaboration with three pharmaceutical companies, have developed a radioligand that facilitates the imaging of α-synuclein aggregates in patients with MSA. Their findings have the potential to completely change the scenario of diagnosing neurodegenerative diseases.
